We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$186B
AUM Growth
+$16.6B
Cap. Flow
+$3.17B
Cap. Flow %
1.7%
Top 10 Hldgs %
15.55%
Holding
3,227
New
50
Increased
2,329
Reduced
489
Closed
48

Sector Composition

Rank Sector Weight
1 Technology 18.04%
2 Financials 14.33%
3 Healthcare 12.99%
4 Industrials 10.19%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEAF
3076
DELISTED
Leaf Group Ltd.
LEAF
$144K ﹤0.01%
35,960
KZR
3077
DELISTED
Kezar Life Sciences
KZR
$141K ﹤0.01%
3,506
BXRX
3078
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$133K ﹤0.01%
+14
New +$119K
LQDA icon
3079
Liquidia Corp
LQDA
$8.1B
$132K ﹤0.01%
30,682
TPST icon
3080
Tempest Therapeutics
TPST
$16.6M
$132K ﹤0.01%
100
LOGC
3081
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$131K ﹤0.01%
18,169
MBII
3082
DELISTED
Marrone Bio Innovations, Inc.
MBII
$131K ﹤0.01%
129,430
MJCO
3083
DELISTED
Majesco
MJCO
$130K ﹤0.01%
15,678
ACET icon
3084
Adicet Bio
ACET
$75.9M
$128K ﹤0.01%
765
-94
-11% -$47.6K
LVO icon
3085
LiveOne
LVO
$60.4M
$127K ﹤0.01%
8,178
MEC icon
3086
Mayville Engineering Co
MEC
$584M
$123K ﹤0.01%
13,093
IMDX
3087
Insight Molecular Diagnostics
IMDX
$154M
$122K ﹤0.01%
2,704
SND icon
3088
Smart Sand
SND
$197M
$122K ﹤0.01%
48,150
SOLY
3089
DELISTED
Soliton, Inc.
SOLY
$122K ﹤0.01%
11,097
CHAP
3090
DELISTED
Chaparral Energy, Inc.
CHAP
$114K ﹤0.01%
64,581
WATT icon
3091
Energous
WATT
$102M
$112K ﹤0.01%
105
ICD
3092
DELISTED
Independence Contract Drilling, Inc.
ICD
$108K ﹤0.01%
5,393
MCF
3093
DELISTED
Contango Oil & Gas Co.
MCF
$107K ﹤0.01%
29,038
+15,000
+107% +$44.1K
WRAP icon
3094
Wrap Technologies
WRAP
$102M
$102K ﹤0.01%
15,825
XELA
3095
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$102K ﹤0.01%
21
-2
-9% -$14.1K
UTI icon
3096
Universal Technical Institute
UTI
$1.47B
$101K ﹤0.01%
13,059
SER icon
3097
Serina Therapeutics
SER
$40M
$100K ﹤0.01%
1,560
SYBX
3098
DELISTED
Synlogic
SYBX
$96K ﹤0.01%
2,481
IDEX
3099
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$92K ﹤0.01%
851
LYTS icon
3100
LSI Industries
LYTS
$909M
$90K ﹤0.01%
14,777

Similar funds

Charles Schwab's Q4 2019 Portfolio in Review

As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
  • Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
  • Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
  • Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
  • Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
  • Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
  • Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.

Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.